Investor Relations

Frontage is a science-driven, global CRO focused on providing research and development services to the pharmaceutical, biotechnology, agrochemical, animal health and chemical industries.

Investor Relations

Invest in Frontage

We offer biopharmaceutical and life science companies enhanced and integrated services to help them meet their product development goals.

With operations in North America (including the U.S. and Canada) and China, we are strategically positioned to capture growth opportunities in these two largest economies in the world. In North America and China, the Group provides a comprehensive portfolio of services, including drug discovery, drug development, pharmaceutical product development, and laboratory testing services.